A number of non-human-mu eiencvirus (HIV) type 1 disorders are associated with CD4+ T-cell deficiency and dysfunction. However, the etiopathogenesis of CD4+ T-cell immunodeficiency in these disease states remains unclear. Human in sternal retroviral (HICRV) particles were detected in a lymphoblastoid cell line exposed to mononuclear cells from a patient with severe CD4+ T-cell deficiency without risk factors for HIV infection. Ultrastructurally, the HICRV is distinct from HIV-1i, HIV-2, human T-lymphotropic virus (HITLV) type I, and HTLV-II. Supernatants of activated mononuclear cells showed ificant reverse trunscriptase activity that was predominantly Mn2+ dependent. The patient's mononuclear cells were negative for HIV-1, HIV-2, HTLV-I, and HTLV-i proviruses as demonstrated by the lack of amplification by PCR. Also, the patient's serum was negative for antibodies to HIV-1, HTLV-I, and HTLV-iH and for HIV-1 p24 antigen; however, serum was positive for antibodies against the HICRV as demonstrated by Western blot. Similar HICRV particles were detected in a lymphoblastoid cell line exposed to mononuclear cells from the patient's daughter, who showed CD4+ T-cell dysfunction. The HICRV may be associated with CD4+ T-cell immunodeficiency and dysfunction in patients without risk for HIV-1, HIV-2, HTLV-I, and HTLV-U.
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Human retroviruses are associated with several human diseases that involve disturbances of the growth of CD41 T lymphocytes (1) . Human T-lymphotropic virus (HTLV) type I is associated with malignant expansion of CD41 T cells (2) , whereas human immunodeficiency virus (HIV) type 1 is associated with depletion of CD41 T cells, resulting in AIDS (3) (4) (5) . Recently, a human intracisternal A-type retroviral particle was isolated from lymphoblastoid cells exposed to homogenates of salivary gland from Sjogren syndrome (6) . The latter virus was antigenically related to HIV-1 p24. No relationship to CD4+ T-cell deficiency was reported. A number of non-HIV-1 disease states are associated with CD4+ T-cell deficiency (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Jacobs et al. (18) have described a cluster of HIV-1-negative patients with Pneumocystis carinji pneumonia without predisposing illness, some of whom had T-cell defects. More recently, Gautier et al. (19) reported three cases ofP. carinji pneumonia associated with CD4+ T-cell deficiency. No HIV-1 antibody or HIV-1 antigen was found during 1 year of follow-up. However, the etiopathogenesis of immune deficiency in these subjects remains unclear. In the present report, we demonstrate the presence of a human intracisternal retroviral (HICRV) particle in a lymphoblastoid cell line (H9) and in peripheral blood mononuclear cells (MNC) from a healthy control that were exposed to MNC from a 66-year-old patient who had a severe CD4+ T-cell deficiency ( embedded blocks were cut at a thickness of 50-60 nm, contrast enhanced with uranyl acetate, and examined with a Philips CM 10 electron microscope.
RT Activity. Supernatants of PHA-plus rIL-2-activated MNC of the patient and H9/200 cells were collected at various time intervals and examined for precipitable RT activity. Supernatants were centrifuged at 10,000 x g for 15 min and treated with polyethylene glycol 8000 [30%o (wt/vol) with 0.4 M NaCl]. The mixture was maintained overnight at 4°C. All specimens were centrifuged at 10,000 x g for 45 min at 4°C. Supernatants were discarded, and pellets were resuspended in 100 ,ul of buffer containing Triton X-100. Specimens were frozen at -70°C until analyzed. Negative controls consisted of supernatants of PHA-plus IL-2-activated MNC and the H9 cell line and medium alone. Positive controls consisted of supernatants from HIV-1 (Mg2+-dependent RT)-infected H9 cells and simian sarcoma virus (SSV) (Mn2+-dependent RT). Precipitable RT activity was measured in the presence or absence of Mn2+ (0.3 mM) or Mg2+ (10 mM) as divalent cations and dT12.18 poly(rA) and dG12_18 poly(rC) as synthetic primer templates (22) . Data are expressed as cpm.
PCR for HIV and HTLV Proviruses. Genomic DNA was prepared by the proteinase K/phenol extraction method (23) from H9/200 cells, U1 (HIV-1-infected) cells, and MT-2 (HTLV-I-infected) cells. Genomic DNA from MNC of a normal donor was used as a negative control. One-half microgram of each DNA was used as template for PCR. Primers SK145 and SK431 were designed to amplify DNA in the gag region of both HIV-1 and HIV-2 proviruses. Primers SK43 and SK44 were used to amplify DNA in the tax region of both HTLV-I and HTLV-II proviruses. PCR was done with a thermal cycler and GeneAmp PCR kit for 42 cycles of 1 min at 940C, 1 min at 600C, and 3 min at 720C. Amplified DNA was analyzed with 2% agarose gel electrophoresis. Amplified DNA was confirmed by Southern hybridization analysis with SK102 and SK45 probes for HIV and HTLV proviruses, respectively. To demonstrate the sensitivity of our PCR assay, experiments were performed with DNA isolated from U1 and MT-2 cells that were mixed with DNA from normal peripheral blood lymphocytes to obtain the final amount of DNA equivalent to that from 100%6, 10%6, 1%, 0.1%, and 0.01% infected cells.
Detection The intracisternal viral particles were uniform in morphology, =80 nm in diameter with two concentric rings of electrondense material and a clear center. The inner core was considerably thicker than the outer layer. Spikes were also noted on the outer surface. Twenty to 30 particles in each cell were seen in individual thin sections. Control H9 cells showed no viral particles (Fig. ID) . Fig. 1C shows the presence of similar intracisternal viral particles in cocultures of H9 cells with MNC from the patient's daughter. In addition, we have been able to transfer HICRV infection in vitro (as determined by electron microscopy) from the MNC of the daughter to MNC from a healthy control (data not shown). Since progressive cell death was observed in cocultures ofH9/200 (without syncytia formation), it was reasoned that the virus must be released in the cultured medium. To transfer the viral infection from culture supernatants to normal MNC, supernatants from H9/200 cells were filtered and centrifuged at 10,000 x g for 15 min to remove cellular debris. Supernatants were then centrifuged at 40,000 x g for 8 hr at 40C, and pellets were used as virus inoculum to infect PHA-plus rIL-2-activated MNC from a normal healthy donor. After 2-3 weeks in culture, cells were examined with an electron microscope. Intracisternal viral particles similar to those seen in H9/200 cells were detected (data not shown).
RT Activity. Culture supernatants from the patient's MNC stimulated with PHA plus rIL-2 were examined for precipitable RT activity in the presence or absence of divalent Proc. Natl. Acad. Sci. USA 89 (1992) cations Mg2+ or Mn2+, using dT12_18poly(rA) and dG12_18 poly(rC) as synthetic templates. Fig. 2A shows a significant RT activity that was predominantly Mn2+ dependent. At day 7 onward, progressive cell death was observed in cultures. Similar Mn2+-dependent RT activity was observed in the supernatant of HICRV-infected H9 cells (Fig. 2B) . The positive (SSV for Mn2+-dependent RT and HIV-1 for Mg2+-dependent RT) and negative controls (MNC, H9, and medium) for both experiments are shown in Fig. 2B .
PCR. To further distinguish HICRV from HIV or HTLV, PCR analysis was performed with genomic DNA isolated from H9/200 cells, U1 cells, and MT-2 cells. DNA from a normal donor's mononuclear cells was used as a negative control. Fig.   3 shows that PCR failed to amplify HIV and HTLV proviruses from genomic DNA of the patient's MNC, whereas 142-basepair and 159-base-pair DNA in U1 and MT-2 were amplified from HIV and HTLV proviruses, respectively. (Fig. 4A) . Normal serum showed no band at 24 kDa (Fig. 4B) . To (Fig. 5) . These data demonstrate that the 24-kDa band in H9/200 cells is not shared by HIV-1 p24. Therefore, HICRV p24 appears to be antigenically distinct from that of HIV-1. The data also show the presence of antibodies in the patient's serum against the 24-kDa protein of HICRV.
DISCUSSION
In the present study we have isolated HICRV particles from a 66-year-old patient with severe CD4+ T-cell deficiency and P. carinji pneumonia and her 38-year-old asymptomatic daughter with CD4+ T-cell dysfunction. Neither the patient nor her daughter had any risk factors for HIV infection and were negative for antibodies to HIV-1, HTLV-I, and HTLV-II, and for HIV-1 p24 antigen. Furthermore, in the patient, (6) isolated a human intracisternal A-type retroviral particle from a-lymphoblastoid cell line exposed to homogenates of salivary gland from Sjogren syndrome. It is unclear whether lymphocytes from patients with Sjogren syndrome were infected with this virus. Moreover, no association with CD4+ T-cell deficiency and dysfunction was reported. Although ultrastructurally and enzymatically HICRV is similar to the A-type intracisternal retroviral particle, it is distinct from the intracisternal A-type retrovirus as demonstrated by a lack of HIV-1 and HIV-2 proviruses in the patient's cells, a lack of reactivity of anti-HIV-1 p24 antibody with the 24-kDa protein of HICRV, In this study, we have shown the presence of circulating antibodies in the patient's serum against a protein of :24 kDa (likely Gag protein) by Western blot. Furthermore, this 24-kDa band is not recognized by monoclonal antibodies to HIV-1 p24, suggesting that the HICRV 24-kDa protein is antigenically distinct from that of HIV-1 p24. A cluster of patients with P. carini pneumonia have been reported in HIV-1-negative subjects without any predisposing factors (18) . More recently, Gautier et al. (19) have reported three unusual cases of P. carinji pneumonia associated with CD41 T-cell deficiency in whom there was no evidence of HIV-1 infection over a 1-year follow-up. Our present patient is similar to those described by Gautier et al. Her immunodeficiency has persisted for the past 18 months. It is possible that some of these patients with CD4+ T-cell deficiency and dysfunction are infected with HICRV.
The mode of transmission of HICRV is presently unclear.. A possibility of transmission of HICRV through blood transfusion is entertained. Our patient had a history of blood transfusion in 1949-1950 for bleeding following a spontaneous abortion. HICRV also appears to be vertically transmitted as demonstrated by the presence of HICRV particles in H9 cells cocultured with the MNC from the daughter of the patient. The daughter had normal proportions and numbers of CD4+ T cells; however, a functional defect of CD4+ T cells, as demonstrated by a poor proliferative response to soluble antigens (Candida albicans, mumps, and tetanus toxoid) was observed. The proliferative responses to mitogens (PHA, Con A, and pokeweed mitogen) were normal. These immunological abnormalities were reproducible over a 6-month period (data not shown). A similar immunological profile has been observed in early stages of HIV-1 infection (24, 25) .
In summary, we have identified a human retrovirus (HICRV) from a patient with CD41 T-cell deficiency and P.
carinji pneumonia and her asymptomatic daughter with CD4+ T-cell dysfunction. HICRV is distinct from HIV-1, HIV-2, HTLV-I, HTLV-II, and intracisternal A-type retrovirus. The causal relationship of HICRV to CD41 T-cell deficiency remains to be established. Additional modes of transmission, cell tropism, receptor(s) for HICRV, etc. remain to be defined. A possibility of HICRV infection should be entertained in patients with CD4+ T-cell deficiency and/or dysfunction, with or without opportunistic infections, in whom HIV and HTLV infections have been excluded.
